OWCP vs SFOR.. which will reach $1 first? Difficult to

New Post Public Reply Private Reply Replies (0) Message Board
joey68
OWCP vs SFOR.. which will reach $1 first?

Difficult to say. Here are my thoughts:

OWCP
OWCP is already at .16 cents. .84 more cents and it hits $1
OWCP has lots of momentum right now. Investors (including myself) know this sector of the market is very hot right now and will continue to be for years ahead.
OWCP has an incredibly low OS with only 81 million shares
OWCP just LOWERED the share count by 15 million. Most pennystocks raise the share count. Not OWCP.
With such a low share count, it will take absolute minimal effort to raise the share price. Plus, no convertible debt means nothing holding it back.


SFOR
SFOR already won a lawsuit against Microsoft.
SFOR will have a shareholders meeting this November.
SFOR never has shareholder meetings which means more than likely they have some good news.
SFOR is already at a penny and has successfully sustained its share price for many trading days.
SFOR's tech was infringed upon by many companies. Chances are, at least one product or service you use is using SFOR's technology.
It's possible SFOR may settle against the three companies soon.
It's possible SFOR will be bought out soon.

At this stage, and lacking the ability to see the future (I lost this ability last month) I would have to guess OWCP will reach $1 first..

..and here's why:

1. Momentum. OWCP jumped from .05 cents to .21 cents in a mere 5 trading days.

2. The chart. Oct 6 to Oct 17 shows a clear continuation pattern. OWCP closed with a continuation candle last Friday. Could this pattern continue? I think it may.

3. SFOR is expected to meet in November. Chances are SFOR won't release any new information until then. On the other hand, OWCP may release more information this and next week. Even if they don't, OWCP has momentum.

4. Share price. Many investors will not invest under .10 cents. OWCP is well above .10 cents now which means many new investors will start noticing OWCP on their stock screener software.

Conclusion:
I believe OWCP will reach $1 before SFOR.

Note:
Not written in stone. I stopped writing in stone a few years ago (rough on the fingers). Not investment advice.
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 24

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 33

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 28

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 18

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 37

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 46

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 30

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading

Top 5 Most Recently Viewed Articles

Lead Plaintiffs Sought in Match Group, Inc. Securities Case

Updated Category News Views 233

Overview of the Match Group, Inc. Securities Case Rosen Law Firm, a prestigious global investor rights law firm, has announced a class action lawsuit for investors of Match Group, Inc. (NASDAQ: MTCH). This lawsuit pertains to securities purchased between May 2, 2023, and November 6, 2024. If you bought Match Group securities during this stated period, you could be part of...

Continue Reading
Superalloys Market Growth Forecasts Driven by Industry Demand

Updated Category News Views 145

Superalloys Market Overview SkyQuest reports that the Superalloys Market is projected to experience substantial growth in the coming years, reaching an estimated value of USD 13.47 billion by 2031. This expansion represents a remarkable compound annual growth rate (CAGR) of 9% throughout the forecast period from 2024 to 2031. The notable increase in demand for advanced...

Continue Reading
Exploring AI's Impact on Customer Service Agents and Experience

Updated Category News Views 125

Transforming Customer Service with AI Insights In a world where customer expectations are constantly evolving, organizations are facing significant challenges in providing exceptional service. The emergence of artificial intelligence (AI) brings promising solutions to address long-standing issues such as lengthy wait times, lackluster interactions, and inefficient...

Continue Reading
Sara Howe Honored with the Anne Doolen Visionary Award

Updated Category News Views 148

Sara Howe Honored with the Anne Doolen Visionary Award The Addiction Professionals of North Carolina (APNC) is delighted to announce a prestigious recognition for its Chief Executive Officer, Sara Howe. She has been awarded the Anne Doolen Visionary Award, celebrating her substantial contributions and leadership within the realm of behavioral health and addiction...

Continue Reading
Alida Biosciences Partners with Baylor for RNA Sequencing Innovations

Updated Category News Views 187

Alida Biosciences Partners with Baylor College of Medicine Alida Biosciences, a leader in next-generation RNA modification analysis, is excited to announce its inaugural service provider collaboration with the Genomic and RNA Profiling (GARP) Core at Baylor College of Medicine. This partnership marks a significant milestone in their mission to enhance RNA analysis...

Continue Reading